Brain Cancer Clinical Trials

Showing 261-280 of 693 trials

Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma

NCT03661723

This research study is studying pembrolizumab and re-irradiation as possible treatments for glioblastoma. The drugs involved in this study are: * Pembrolizumab * Radiation * Bevacizumab, an FDA-approved drug for treating recurrent glioblastoma multiforme (GBM)

Glioblastoma

Dana-Farber Cancer Institute60 participantsStarted Sep 2018

Boston, Massachusetts, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +2 more locations

COMPLETEDEARLY_PHASE1

Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0

NCT03995706

Single center, non-randomized, Phase 0 study. Sacituzumab Govitecan given preoperatively, followed by craniotomy with surgery or biopsy of brain tumors (GBM and metastatic brain tumors from Breast) and intraoperative tissue collection will follow with contemporaneous CSF (depending on tumor location) and whole blood (serum) sampling.

Glioblastoma

The University of Texas Health Science Center at San Antonio26 participantsStarted Jul 2019

San Antonio, Texas, United States

Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma

Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0

Related Searches

USPIO Enhanced MR Imaging in CNS Tumours (UMIC)

Communication Training for Caregivers In Advanced Care Planning

Record Voxel Rate Nonlinear Optical Microscope to Unravel Brain Connectome and Signaling

Wearable Devices and Biomarkers Project (Healthiomics)

Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma

18F-FET PET/CT in the Management of Glioma

Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM

Erivedge (Vismodegib) in the Treatment of Pediatric Patients With Refractory Pontine Glioma

Research on the Safety and Efficacy of Blocking Dural Blood Supply in Glioblastoma Patients

Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors

OPTIMIZATION of ADVANCED MR SEQUENCES

Expectations and Needs of a Glioblastoma Caregiver

CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma

FET-PET-Guided Management of Pseudoprogression in Glioblastoma

Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients

18F-FluorThanatrace (PET/CT) in Glioblastoma

A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)

The Incidence and Outcomes of Metabolically Active Brown Adipose Tissue (aBAT) in Patients With Pheochromocytoma or Paraganglioma (PPGLs)